Where are we going for the treatment in ischaemic stroke: a comprehensive study of investigator-sponsored randomised controlled trials, 1990–2024
Background Until recently, a comprehensive understanding of the current development status and emerging trends of investigator-sponsored randomised controlled trials (RCTs) for the treatment of ischaemic stroke (IS) on a global scale remains elusive, making it unclear where the research and innovati...
Saved in:
Main Authors: | Anxin Wang, Xue Tian, Meng Gao, Xinya Li, Xue Xia, Ruobing Tian, Manqi Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
|
Series: | Stroke and Vascular Neurology |
Online Access: | https://svn.bmj.com/content/early/2025/07/30/svn-2025-004027.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Breast Implant Illness: where are we and where are we going?
by: Ricardo Votto, et al.
Published: (2022-03-01) -
Scientific contribution of Turkey in prostate literature. Where are we? Where are we going?
by: Selahattin Çalışkan, et al.
Published: (2017-12-01) -
Comparative effectiveness and safety of atorvastatin versus rosuvastatin among patients with ischemic stroke or transient ischemic attack: a national registry-based observational studyResearch in context
by: Jianhua Zhao, et al.
Published: (2025-08-01) -
Where Are We and Where Are We Going: Experts on Cultural Competence in the Slovenian Healthcare System
by: Helena Kristina Halbwachs, et al.
Published: (2025-06-01) -
Where do we go from here?
by: Kamm, Josephine
Published: (1974)